Eric van Roon

Professor Eric van Roon is a distinguished academic and clinical pharmacologist affiliated with the University of Groningen's Faculty of Science and Engineering, specifically within the PharmacoTherapy, Epidemiology and Economics department of the Groningen Research Institute of Pharmacy. He simultaneously maintains an active clinical role as a Clinical Pharmacologist at Medisch Centrum Leeuwarden, demonstrating a strong integration between academic research and clinical practice.

His research interests span multiple areas of pharmacology with particular focus on drug therapy applications in rheumatoid arthritis, multiple myeloma, anticoagulation management, and pharmacotherapy for elderly patients. Professor van Roon has made significant contributions to clinical decision support systems and drug utilization studies, with research that often bridges the gap between theoretical pharmacology and practical clinical implementation.

Analysis of his recent publications reveals a strong emphasis on practical clinical applications of pharmacological research, with particular attention to special patient populations including the elderly and those with complex comorbidities. His work frequently addresses medication safety, treatment adherence, and the implementation of evidence-based practices in real-world settings.

Professor van Roon holds several prestigious positions that reflect his standing in the field:

• Member of the Scientific Board Committee Drugs at Zorginstituut Nederland
• Vice-president of Ethical Committee RTPO
• President of the Committee on Scientific Research (CWZO) of the NVZA
• Core team member of Expert Centre Pharmacotherapy for the Elderly (EPHOR)
• Member of the Multidisciplinary NVR Working Group on Gout

His research has been widely disseminated with 279 documented research outputs, including numerous peer-reviewed articles, editorials, and contributions to professional literature. He has supervised 9 students through their academic work, contributing to the development of the next generation of pharmacologists and clinical researchers.